Skip to main content
Caplight Logo









MantaBio

MantaBio

Private
Beverly, MassachusettsHealthcare & Life Scienceshttps://mantabio.com

Last Round

Seed

May 13, 2025

Total Funding Raised

$2.5M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

MantaBio operates in Healthcare & Life Sciences and is based in Beverly, Massachusetts. Its latest recorded funding round was a Seed round in May 2025.

MantaBio is a biotechnology company that has developed a real-time polymerase chain reaction (PCR) platform designed for automated microbial contamination detection for biopharma applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Smart Manufacturing, Quality Management

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

MantaBio Comparables

Compare MantaBio with similar companies based on industry and business-model similarity.

MantaBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
IntuBio ApS
78%
Lonza Group
77%
Spore.Bio
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

MantaBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 13, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Jack Regan

CEO and Founder

Founding Team

Carter Boisfontaine

Chief Operating Officer

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 31, 2026

    Open roles increased to 3, 3x the trailing average.

Book a demo to see all signals

For institutional investors. Book with your work email.

MantaBio Filings

Explore SEC and related filing metadata, where available.

MantaBio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about MantaBio's valuation, stock price, and market status.

Is MantaBio a public or private company?

MantaBio is a private company.

What is the current stock price of MantaBio?

MantaBio is a private company, so its shares have no public market price. Caplight tracks MantaBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is MantaBio worth (valuation)?

Valuation information for MantaBio is not publicly available.

Can I buy MantaBio stock?

MantaBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was MantaBio's last funding round?

MantaBio's most recent funding round was Seed on May 13, 2025.

Who are the main investors in MantaBio?

Investor information for MantaBio is not publicly disclosed.

Will MantaBio IPO soon?

No public IPO plans have been announced for MantaBio.

How can I track MantaBio secondary market activity?

Caplight tracks bids, offers, and trades in MantaBio's shares on secondary markets.

Firmographic Details

HeadquartersBeverly, Massachusetts
Employee Range6
Year Founded2025
Last FundingMay 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?